Heart Test Laboratories, Inc.Heart Test Laboratories, Inc.Heart Test Laboratories, Inc.

Heart Test Laboratories, Inc.

No trades
See on Supercharts
Market capitalization
‪6.72 M‬USD
−0.4840USD
‪−6.35 M‬USD
‪5.15 K‬USD
‪44.37 M‬
Beta (1Y)
1.41

About Heart Test Laboratories, Inc.

CEO
Andrew Christopher Simpson
Headquarters
Southlake
Employees (FY)
12
Founded
2008
ISIN
US42254E1047
FIGI
BBG0185L0044
Heart Test Laboratories, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded in 2008 and is headquartered in Southlake, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HSCS is 0.10 USD — it has increased by 1.46% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Heart Test Laboratories, Inc. stocks are traded under the ticker HSCS.
Heart Test Laboratories, Inc. is going to release the next earnings report on Jul 17, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Heart Test Laboratories, Inc. has a max estimate of 1.00 USD and a min estimate of 0.35 USD.
HSCS earnings for the last quarter are −0.16 USD whereas the estimation was −0.12 USD which accounts for −33.33% surprise. Estimated earnings for the next quarter are −0.06 USD. See more details about Heart Test Laboratories, Inc. earnings.
Yes, you can track Heart Test Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, HSCS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Heart Test Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.
HSCS reached its all-time high on Aug 3, 2022 with the price of 6.00 USD, and its all-time low was 0.10 USD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 12.00 employees. See our rating of the largest employees — is Heart Test Laboratories, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Heart Test Laboratories, Inc. EBITDA is ‪−6.00 M‬ USD, and current EBITDA margin is ‪−118.18 K‬%. See more stats in Heart Test Laboratories, Inc. financial statements.